Sign Up to like & get
recommendations!
0
Published in 2021 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2021.771910
Abstract: Objectives: This work was to investigate the activity and optimal treatments of ceftazidime-avibactam (CZA) and aztreonam-avibactam (AZA) against bloodstream infections caused by carbapenem resistant Klebsiella pneumoniae (BSIs-CRKP). Methods: A total of 318 nonduplicate BSIs-CRKP isolates…
read more here.
Keywords:
aztreonam avibactam;
avibactam;
ceftazidime avibactam;
infusion ... See more keywords